Fierce Healthcare

JANUARY 16, 2024

Industry Voices—Oncology researchers must rethink their definition of what is considered a "good" clinical research site hlandi Tue, 01/16/2024 - 12:49

52

52

Pharmacy Times

OCTOBER 14, 2022

Presenters at the AMCP Nexus conference explore outcomes data and whether these medications should be substituted for reference products more frequently.

161

161

PharmExec

AUGUST 16, 2022

Wed, Aug 17, 2022 2:00 PM EDT Recent advances in both oncology drug development and novel digital technologies provide a ripe opportunity to enhance the clinical trial process. Join Colin Weller and Musaddiq Khan from Medable as they discuss the key considerations around these innovations.

52

52

Pharma Mirror

JUNE 8, 2022

According to the Endpoints ASCO session: “China and the US are the world’s largest oncology research destinations, and the. The post Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in China appeared first on Pharma Mirror Magazine.

52

52

Pharmacy Times

APRIL 5, 2024

Lisa Janssen Carlson, PharmD, BCOP, discusses some background and history of regulations for the conduct of clinical trials.

50

50

Fierce Pharma

DECEMBER 6, 2022

SABCS: After Enhertu's modest showing in neoadjuvant breast cancer, Daiichi Sankyo's clinical oncology chief wants to see more. fkansteiner. Tue, 12/06/2022 - 17:08.

58

58

Fierce Healthcare

DECEMBER 4, 2023

Maia Oncology raised $4.25 Five years ago, Liya Shuster-Bier entered cancer as an otherwise healthy 29-year-old. million in seed funding to hone its go-to-market strategy, hire more talent and launch its first pilot in partnership with a cancer center and health insurance company.

Health Insurance Companies 125

Health Insurance Companies Insurance 125

Pharmacy Times

NOVEMBER 3, 2022

In the inpatient acute care setting, oncology pharmacists maximize return on investments of oncology products, produce optimal outcomes, and ensure that quality of care is consistent and safe.

123

123

Pharmaceutical Technology

MARCH 27, 2024

We analyze the biggest trends in oncology and the technological solutions available to CROs to optimize efficiencies. CROs are fundamental to the development of cancer treatments but face multiple challenges.

52

52

PharmExec

APRIL 3, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

PharmaShots

FEBRUARY 23, 2023

Shots: MEI Pharma signs a merger agreement with Infinity for an all-stock transaction forming a new company to advance 3 clinical-stage oncology drug candidates The combined company will have ~$100M cash balance expected to fund planned studies into mid-2025 supporting clinical data over the next 12-24mos.

40

40

Pharmacy Times

APRIL 25, 2024

Dostarlimab plus chemotherapy is the only immuno-oncology-based therapy that showed statistically significant and clinically meaningful survival benefit in the overall patient population.

Chemotherapy 65

Chemotherapy FDA 65

PhRMA

JUNE 8, 2023

Last week, I traveled to the American Society of Clinical Oncology’s (ASCO) annual meeting. It’s always an exceptional meeting where the brightest minds in oncology, including researchers, health care providers and industry stakeholders gather to learn about the latest advancements in cancer research and development (R&D).

206

206

Pharmacy Times

SEPTEMBER 26, 2023

As the resident medication experts, pharmacists are qualified to answer any medication-related questions and conduct data analyses.

73

73

Pharmacy Times

FEBRUARY 1, 2024

The late-breaking data at the 2024 American Society of Clinical Oncology Genitourinary Cancers Symposium included the results of KEYNOTE-123 for locally advanced resectable urothelial carcinoma.

136

136

Pharmacy Times

MARCH 5, 2024

The CORe initiative is aimed at promoting inclusivity, reducing startup time for clinical trials, and facilitating data sharing to address recruitment and retention challenges in cancer research at community oncology sites.

121

121

PharmaVoice

APRIL 23, 2024

Mark Wildgust, vice president of global medical affairs for J&J's oncology division, shares strategies for making clinical trials gender- and trans-inclusive.

80

80

Pharmaceutical Technology

JANUARY 19, 2024

Ikena has also paused exploratory research and discovery in addition to workforce reduction, which will occur over Q1 this year.

52

52

Pharmacy Times

JUNE 8, 2023

The meeting aims to bring together pharmacists to discuss solutions for responding to the rapidly evolving evidence and needs for effective implementation.

Patient Care 65

Patient Care 65

STAT

MARCH 20, 2024

Robert Ross had thought he would take more time off after his previous company, Surface Oncology, was acquired in September.    The immuno-oncology firm had just managed to weather the stormy public markets, which had battered its valuation.   Continue to STAT+ to read the full story…

123

123

Outsourcing Pharma

DECEMBER 10, 2020

Health Decisions and OncoBay Clinical will collaborate on specialized clinical development services addressing therapies for womenâs cancers.

81

81

Pharma Mirror

FEBRUARY 25, 2022

The post Abzena, Alira Health and Oncodesign launch DRIVE Biologics to support access to specialist services from discovery to clinical development for oncology and inflammation appeared first on Pharma Mirror Magazine.

52

52

European Pharmaceutical Review

MARCH 5, 2024

BeiGene has appointed Pilar de la Rocha as its new Head of Europe, Global Clinical Operations. The biotech’s new appointment underlines its commitment to advancing clinical development initiatives in the European region. The company highlighted that 35 percent of patients enrolled in its clinical trials are based in Europe.

Medical Schools 96

Medical Schools 96

STAT

FEBRUARY 22, 2024

In the years leading up to Russia’s invasion, Ukraine had become a burgeoning hub of clinical trials, particularly in oncology. The war put a hold on the vast majority of those studies.

142

142

PharmExec

MARCH 14, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

Outsourcing Pharma

OCTOBER 17, 2022

to improve cancer clinical trial enrolment through the use of AI technology to connect oncologists and patients with biomarker-based therapy options. Massive Bio partners with Perthera.ai

52

52

PharmExec

JANUARY 9, 2024

Merck has acquired Harpoon Therapeutics with its clinical stage T-cell engager, whereas Johnson & Johnson acquired Ambrx Biopharma with its expertise in next generation antibody drug conjugates and targeted oncologic therapies.

115

115

Outsourcing Pharma

JANUARY 29, 2024

Clinical-stage precision oncology company, Repare Therapeutics Inc., has received a $40 million milestone payment from Roche after dosing the first patient in a clinical trial.

89

89

STAT

JANUARY 25, 2024

Some takes and thoughts on Gilead’s Trodelvy troubles, Elevation Oncology’s surprising rise, and Kura Oncology’s “wall-crossing” stock sale.

103

103

Hospital Pharmacy Europe

DECEMBER 18, 2023

To this end, the Society of Geriatric Oncology and the French Society of Oncology Pharmacists have published a position paper to support this collaboration. Here, Chloé Herledan PharmD PhD, pharmacist, Clinical Oncology Pharmacy Unit, Hospices Civils de Lyon and Université Claude Bernard Lyon 1, Lyon, France, shares an overview.

Chemotherapy 96

Chemotherapy Hospitals Labelling Communication 96

European Pharmaceutical Review

SEPTEMBER 1, 2023

The global mRNA-based oncology therapy market is expected to reach $2 billion by 2029, according to GlobalData. Global mRNA-based oncology therapy market At present, the pharmaceutical industry is still awaiting the first regulatory approval of an mRNA-based oncology therapy. percent share by 2029, the research has shown.

Immunization 97

Immunization Vaccines 97

STAT

SEPTEMBER 25, 2023

Like most small community practices, Rice’s clinic has always kept “just in time” inventory – or just enough stock to last the clinic the next few days. Pharmacy technicians would order more drugs each day to keep the clinic running until, one day, they couldn’t.

Chemotherapy 133

Chemotherapy Hospitals 133

Fierce Pharma

OCTOBER 5, 2023

Judgment Day has come for Amgen’s first-in-class KRAS inhibitor Lumakras as the FDA’s Oncologic Drugs Advisory Committee (ODAC) gathered Thursday to weigh the merits of the cancer med’s phase 3 cli | Judgment Day has come for Amgen’s first-in-class KRAS inhibitor Lumakras as the FDA’s Oncologic Drugs Advisory Committee gathered Thursday to weigh the (..)

FDA 109

FDA 109

Fierce Pharma

FEBRUARY 9, 2024

the American Society of Clinical Oncologists (ASCO) is again pushing Congress to act to end the crisis. | The oncology drug supply crisis has entered its second year, and doctors still face "impossible choices" without access to standard-of-care therapies, ASCO's chief medical officer, Dr.

124

124

Pharmacy Times

MARCH 26, 2024

The podcast discusses how City of Hope Chicago fully integrates oncology pharmacists into care teams by positioning them in clinics, improving communication and collaboration to minimize delays for patients and enhance care delivery.

Communication 65

Communication 65

STAT

APRIL 23, 2024

Overall survival is usually considered the gold standard in oncology because people with cancer generally want to take medications that can help them live longer. So judging the FDA’s accelerated approval program without assessing its full impact on overall survival presents a very slanted story.

FDA 110

FDA 110

Pharmacy Times

JUNE 15, 2023

Earlier in June, Govindan led an educational session about genomic testing at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.

123

123